Among various inflammatory mediators, transforming growth factor-β1 (TGF-β1) is one of the most powerful profibrotic cytokines [7,8], and thus, blocking TGF-β1 activity by natural inhibitors represents a valid and logical strategy to combat hepatic fibrosis [8,9]. The gene discussed is TGFB1; the disease is Hepatic fibrosis.